ACD Launches RNAscope TM FFPE Assay Kit, a Breakthrough RNA In Situ Hybridization Product for Clinical Research and Biomarker Validation HAYWARD, Calif., Aug. 10 /PRNewswire/ -- Advanced Cell ...
Advanced Cell Diagnostics (ACD), a Bio-Techne (TECH) spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using ...
MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell ...
Leica Biosystems, a global leader in anatomic pathology solutions and workflow automation, and Advanced Cell Diagnostics, Inc. (ACD), a world leader in RNA biomarker analysis for precision medicine, ...
Advance Cell Diagnostics - a Bio-Techne brand, based in Silicon Valley, ACD's products and pharma assay services are based on its proprietary RNAscope™ technology, the first multiplex fluorescent and ...
Resolving Cell Subtype Specialization with scRNA-seq and RNAscope from thescientistllc on Vimeo. Discover how a combination of single-cell RNA sequencing (scRNA-seq) and quantitative RNA in situ ...
MINNEAPOLIS, July 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ ...
Bio-Techne, which makes proteins for biomedical and clinical researchers, will acquire Advanced Cell Diagnostics for $250 million in cash, with a potential $75 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results